the changing role of allosct in dlbcl in the era of novel agents
Published 1 year ago • 71 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
14:44
the role of allosct in patients with hl who relapse after autosct and the impact of novel agents
-
1:12
the evolving role of allosct in treatment of lymphoma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:37
the changing role of autosct in mantle cell lymphoma: the impact of novel agents
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
24:54
non-hodgkin lymphoma survivor story: mantle cell lymphoma | shari's story, part 1 (diagnosis)
-
1:02:10
plant physiology webinar: plant cell polarity
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:02
the changing standard of care in dlbcl
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
2:53
autohct in dlbcl in the car-t era
-
7:16
changes in the classification of dlbcl
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
1:10
upcoming novel agents for the treatment of sickle cell disease
-
2:09
heart transplantation in attr amyloidosis
-
1:24
conventional approaches for all targeted therapies in allo-hsct
-
1:47
shared treatment decision-making
-
1:21
the role of transplant in the era of new treatments for lymphoma and cll